Elevated Capital Advisors, LLC

Position in LLY — ELI LILLY & Co

CIK 1802387 SANDY, UT

Position in LLY

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$458,182

-$245,442 QoQ

Shares Held

382

-50.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.30%

of 13F equity value

Holder Rank

#3,824

of 4,605 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Elevated Capital Advisors, LLC holds $4,373,518 across 13 Drug Manufacturers - General names. LLY ranks #5 (10.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	4,263	$1,082,674
2	ABBV	AbbVie Inc.	3,945	$992,719
3	AMGN	Amgen Inc	1,865	$675,353
4	PFE	Pfizer Inc	21,185	$510,134
5	LLY	ELI LILLY & Co This page	382	$458,182
6	BMY	Bristol Myers Squibb Co	5,669	$326,647
7	MRK	Merck & Co., Inc.	2,351	$302,103
8	GILD	Gilead Sciences, Inc.	97	$12,254

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$458,182	382	-50.1%	Shares	Sole	2026-08-03
2026-03-31	$703,624	765	-42.2%	Shares	Sole	2026-04-30
2025-12-31	$1,422,876	1,324	-17.8%	Shares	Sole	2026-01-27
2025-09-30	$1,228,430	1,610	-12.2%	Shares	Sole	2025-11-13
2025-06-30	$1,428,878	1,833	0.0%	Shares	Sole	2025-07-15
2025-03-31	$1,513,893	1,833	-9.3%	Shares	Sole	2025-04-24
2024-12-31	$1,560,984	2,022	+48.2%	Shares	Sole	2025-01-13
2024-09-30	$1,208,422	1,364	+20.8%	Shares	Sole	2024-10-22
2024-06-30	$1,022,174	1,129	+6.5%	Shares	Sole	2024-08-01
2024-03-31	$824,637	1,060	-1.8%	Shares	Sole	2024-04-15
2023-12-31	$628,970	1,079	+1.8%	Shares	Sole	2024-01-09
2023-09-30	$569,357	1,060	-5.1%	Shares	Sole	2023-10-17
2023-06-30	$523,850	1,117	+5.6%	Shares	Sole	2023-08-18
2023-03-31	$363,338	1,058	+6.0%	Shares	Sole	2023-04-18
2022-12-31	$365,108	998	—	Shares	Sole	2023-01-17
No filing history on record for this holder in this stock.